Central Adiposity Measures Associated With Psoriasis Risk
By Elana Gotkine HealthDay Reporter
TUESDAY, June 3, 2025 -- Central adiposity measures are strongly associated with psoriasis risk, with a stronger association in women, according to a research letter published online May 27 in the Journal of Investigative Dermatology.
Ravi Ramessur, B.M.B.Sc., from King's College London, and colleagues analyzed data from 336,806 participants in the U.K. Biobank of White British ancestry, including 9,305 with psoriasis, to describe and quantify patterns of adiposity associated with psoriasis. Twenty-five adiposity measures were assessed. To examine how measures conferring the greatest risk for psoriasis relate to genetic determinants of disease, interaction testing was conducted between adiposity measures and psoriasis polygenic risk scores (PRSs).
The researchers found that central adiposity measures, including waist-to-hip ratio, abdominal fat ratio, total abdominal adipose tissue index, and waist circumference were four of the five measures with the largest effect size for association with psoriasis. Of the total adiposity measures, percentage body fat was associated with psoriasis with the largest effect size. In women, the relationship between central adiposity and psoriasis was particularly pronounced. There was a significant interaction between the full psoriasis PRS and waist-to-hip ratio on psoriasis risk. When HLA-C*06:02 was excluded from the PRS, the interaction effect was no longer significant. Waist-to-hip ratio was associated with psoriasis, with a larger effect size in HLA-C*06:02-negative versus HLA-C*06:02-positive individuals.
"Our research shows that where fat is stored in the body matters when it comes to psoriasis risk," Ramessur said in a statement. "Central fat -- especially around the waist -- seems to play a key role. This has important implications for how we identify individuals who may be more likely to develop psoriasis or experience more severe disease, and how we approach prevention and treatment strategies."
Several authors disclosed ties to the biopharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted June 2025
Read this next
ADA: Weight Loss, Type 2 Diabetes Remission Up With Replacing Diet Drinks With Water
WEDNESDAY, June 25, 2025 -- For adult women with overweight or obesity and type 2 diabetes (T2D), replacing diet beverages (DBs) with water is associated with greater weight loss...
Self-Esteem Scores Soar One Year After Metabolic, Bariatric Surgery
TUESDAY, June 24, 2025 -- Self-esteem scores increase after metabolic and bariatric surgery (MBS), with greater improvement in scores for those with higher postoperative weight...
Minor Complications Up for Black Patients After Weight-Loss Surgery
MONDAY, June 23, 2025 -- Black patients have a higher incidence of minor complications after metabolic and bariatric surgery, according to a study presented at the annual meeting...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.